Brain Health

Find More: Dr. Gabrielle Lyon
- Advertisement -
Ad image

Brain Health Articles

MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial

FOR IMMEDIATE RELEASE: August 27, 2024 The Multidisciplinary Association for Psychedelic Studies (MAPS) awarded Emory University researchers a $200,000 grant

A note from Rick on today’s news from the FDA

Our collective commitment to MDMA-assisted therapy remains unwavering Dear friends, I wanted you and all of our supporters to hear

MAPS Statement on FDA Complete Response Letter on MDMA-Assisted Therapy for PTSD New Drug Application

FOR IMMEDIATE RELEASE: August 9, 2024 Aug 9, 2024 – San Jose, CA – The Multidisciplinary Association for Psychedelic Studies

CALIFORNIA, STILL DREAMIN’

Senate Bill 1012 As a reminder,  California Senator Scott Wiener introduced SB 519 in January 2021 following Measure 109’s success

U.S. Sentencing Commission Comment Letter

The post U.S. Sentencing Commission Comment Letter appeared first on Multidisciplinary Association for Psychedelic Studies - MAPS.

Cannabis Descheduling Comment

The post Cannabis Descheduling Comment appeared first on Multidisciplinary Association for Psychedelic Studies - MAPS.

MAPS, MDMA & Beyond Webinar

Join MAPS leaders Kris Lotlikar, Ismail Ali, J.D., Allison Coker, Ph.D., and Betty Aldworth to delve into the approaches and

MAPS Remains Hopeful, Awaits FDA Decision on MDMA-Assisted Therapy for PTSD

Dear Friends and Allies,  On June 4, 2024, the U.S. Food and Drug Administration (FDA) convened a meeting of the

LEGISLATIVE WRAP UP – Summer 2024

The first half of 2024 has been riveting for a few reasons. By now, Oregon’s regulated access program has been